Drug-resistant Plasmodium falciparum parasite poses a great problem for the malaria control programme of any country. The most commonly used antimalarial drugs, viz. chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) have been rendered ineffective and
are replaced by the artesunate-based combination therapy (ACT).